- Investing.com
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
तुलना करने के लिए मीट्रिक्स | NPCE | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधNPCEपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −22.0x | −3.3x | −0.5x | |
PEG अनुपात | −0.74 | −0.11 | 0.00 | |
क़ीमत/बुक | 24.9x | 3.7x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 4.7x | 2.5x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 42.3% | 42.2% | 51.4% | |
उचित मूल्य अपसाइड | अनलॉक करें | 14.0% | 7.1% | अनलॉक करें |